Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Knudsen

Showing results (211-220 of 466) with videos related to

Pageof 47
Sort By:
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Regulation of miR106b cluster through the RB pathway: mechanism and functional targetsChellappagounder Thangavel, Ettickan Boopathi, Adam Ertel, et al.
The Oncologist|June 6, 2022
Real-World Experience with CDK4/6 Inhibitors for Metastatic HR+/HER2- Breast Cancer at a Single Cancer CenterErik S Knudsen, Emily Schultz, Deanna Hamilton, et al.
Gut|January 12, 2017
Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utilityErik S Knudsen, Uthra Balaji, Brian Mannakee, et al.
Chemical Research in Toxicology|May 18, 2004
Succinylacetone oxidation by oxygen/peroxynitrite: a possible source of reactive intermediates in hereditary tyrosinemia type ILeandro O Royer, Fernanda S Knudsen, Marcone A de Oliveira, et al.
Chemical Research in Toxicology|December 21, 2004
Peroxynitrite-initiated oxidation of acetoacetate and 2-methylacetoacetate esters by oxygen: potential sources of reactive intermediates in keto acidosesLeandro O Royer, Fernanda S Knudsen, Marcone A de Oliveira, et al.
Medical Image Analysis|July 18, 2025
CLASS-M: Adaptive stain separation-based contrastive learning with pseudo-labeling for histopathological image classificationBodong Zhang, Hamid Manoochehri, Man Minh Ho, et al.
The EMBO Journal|May 15, 1995
Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteinsB S Knudsen, J Zheng, S M Feller, et al.
Gastroenterology|January 27, 2010
Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cellsDayana B Rivadeneira, Christopher N Mayhew, Chellappagounder Thangavel, et al.
JCO Precision Oncology|January 23, 2026
Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Treated With Cyclin-Dependent Kinase 4/6 InhibitorsThomas N O'Connor, Emily Schultz, Sheheryar Kabraji, et al.
Cell Cycle (Georgetown, Tex.)|October 16, 2010
RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic responseAdam Ertel, Jeffry L Dean, Hallgeir Rui, et al.
Pageof 47

Showing results (211-220 of 466) with videos related to

Sort By:
Pageof 47
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Regulation of miR106b cluster through the RB pathway: mechanism and functional targetsChellappagounder Thangavel, Ettickan Boopathi, Adam Ertel, et al.
The Oncologist|June 6, 2022
Real-World Experience with CDK4/6 Inhibitors for Metastatic HR+/HER2- Breast Cancer at a Single Cancer CenterErik S Knudsen, Emily Schultz, Deanna Hamilton, et al.
Gut|January 12, 2017
Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utilityErik S Knudsen, Uthra Balaji, Brian Mannakee, et al.
Chemical Research in Toxicology|May 18, 2004
Succinylacetone oxidation by oxygen/peroxynitrite: a possible source of reactive intermediates in hereditary tyrosinemia type ILeandro O Royer, Fernanda S Knudsen, Marcone A de Oliveira, et al.
Chemical Research in Toxicology|December 21, 2004
Peroxynitrite-initiated oxidation of acetoacetate and 2-methylacetoacetate esters by oxygen: potential sources of reactive intermediates in keto acidosesLeandro O Royer, Fernanda S Knudsen, Marcone A de Oliveira, et al.
Medical Image Analysis|July 18, 2025
CLASS-M: Adaptive stain separation-based contrastive learning with pseudo-labeling for histopathological image classificationBodong Zhang, Hamid Manoochehri, Man Minh Ho, et al.
The EMBO Journal|May 15, 1995
Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteinsB S Knudsen, J Zheng, S M Feller, et al.
Gastroenterology|January 27, 2010
Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cellsDayana B Rivadeneira, Christopher N Mayhew, Chellappagounder Thangavel, et al.
JCO Precision Oncology|January 23, 2026
Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Treated With Cyclin-Dependent Kinase 4/6 InhibitorsThomas N O'Connor, Emily Schultz, Sheheryar Kabraji, et al.
Cell Cycle (Georgetown, Tex.)|October 16, 2010
RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic responseAdam Ertel, Jeffry L Dean, Hallgeir Rui, et al.
Pageof 47